Here the authors implement a comprehensive timestamping across millions of pieces of biomedical evidence supporting target–disease associations in the Open Targets Platform and analyse trends in evidence supporting novel drug target discovery over the last two decades.
- Maria J. Falaguera
- Ellen M. McDonagh
- Ian Dunham